Yulong Eco-Materials Ltd
Change company Symbol lookup
Select an option...
YECO Yulong Eco-Materials Ltd
HOLX Hologic Inc
FEMY Femasys Inc
HT Hersha Hospitality Trust
SABS SAB Biotherapeutics Inc
DIA SPDR® Dow Jones Industrial Average ETF Trust
SPY SPDR® S&P 500 ETF Trust
ABBNY Abb Ltd
FCF First Commonwealth Financial Corp
ARMN Aris Mining Corp
Go

Health Care : Biotechnology |
Based in China
Company profile

Yulong Eco-Materials Limited is a holding company. The Company is a manufacturer of building products. The Company's segments include Yulong Bricks; Yulong Concrete and Yulong Transport, and Yulong Renewable. The Yulong Bricks segment is engaged in the production and sale of fly-ash bricks. The Yulong Concrete and Yulong Transport segment is engaged in the production and sale of ready-mixed concrete. The Yulong Renewable segment is engaged in the hauling and processing of construction waste, and production and sale of recycled aggregates and recycled bricks. The Company produces fly ash bricks and ready-mixed concrete. The Company's construction waste management (CWM) business includes hauling and processing construction waste, and producing crushed construction waste or recycled aggregates, and bricks made from recycled aggregates, or recycled bricks. The Company operates principally from the city of Pingdingshan, Henan Province, in the People's Republic of China.

Closing Price
$1.50
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.50
Day's Low
1.50
Volume
(Below Average)
Volume:
250

10-day average volume:
659
250

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, October 02, 2023
EV Biologics Updates on Funding and Sales

TAMPA, FL / ACCESSWIRE / October 2, 2023 / EV Biologics Corp, (OTC Pink:YECO), today announced that it has closed a $500,000 interest-free loan from a related party.This funding will provide for further development of exosome - and other...(Accesswire)

EV Biologics Updates on Funding and Sales

TAMPA, FL / ACCESSWIRE / October 2, 2023 / EV Biologics Corp, (OTC Pink:YECO), today announced that it has closed a $500,000 interest-free loan from a related party.This funding will provide for further development of exosome - and other...(Accesswire)

August 16, 2023
EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic

TAMPA, FL / ACCESSWIRE / August 16, 2023 / EV Biologics Corp, OTC PINK:YECO, today announced that it has completed production of a next-generation, "Gen-2", MSC exosome-based therapeutic product.Rigorous product analysis has already begun, and the...(Accesswire)

August 07, 2023
EV Biologics Appoints Senior Investment Banker as Corporate Finance Director

TAMPA, FL / ACCESSWIRE / August 7, 2023 / EV Biologics Corp, OTC PINK:YECO, today announced that it has appointed William Bossung as Corporate Finance Director.Mr. Bossung brings a wealth of experience as a long-time investment banker, with 5...(Accesswire)

August 02, 2023
EV Biologics Hires Senior Chief Financial Officer

TAMPA, FL / ACCESSWIRE / August 2, 2023 / EV Biologics Corp (OTC PINK:YECO) today announced that it has hired Monte Fisher as Chief Financial Officer.Mr. Fisher brings a wealth of experience as a long-time senior employee of Shell Oil, based in...(Accesswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.